# Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies

> **NCT03607149** · PHASE4 · COMPLETED · sponsor: **Centre Georges Francois Leclerc** · enrollment: 11 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT03607149
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-06
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607149, "Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03607149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*